✦ LIBER ✦

266 A phase II study of VP-16 plus ifosfamide plus cisplatin (VIP) plus concurrent radiation therapy (XRT) for previously untreated limited small cell lung cancer (SCLC): A Hoosier Oncology Group (HOG) trial

✍ Scribed by Sandler, A.B.; Ansari, R.; Fisher, W.; Gonin, R.; Levy, R.; Einhorn, L.H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide, ifosfamide and cisplatin (VIP

✍ Hanna, Nasser; Ansari, Rafat; Fisher, William; Shen, Jianzhao; Jung, Sin-Ho; San 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Phase II study of daily oral etoposide p

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 266 KB

A phase III study of VP16 plus cisplatin

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 98 KB

P-774 Phase II study of cisplatin plus e

✍ Kashii, T.; Saito, H.; Negoro, S.; Takada, Y.; Ichinose, Y.; Matsui, K.; Eguchi, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB